Donald R. Swortwood
Directeur/Membre du Conseil chez Vaxiion Therapeutics, Inc.
Profil
Donald R.
Swortwood is currently a Director at Vaxiion Therapeutics, Inc. He was previously the Chairman & Chief Executive Officer at Western States Investment Corp.
and a Director at Lpath, Inc. from 2006 to 2011.
He obtained his undergraduate degree from Stanford University.
Postes actifs de Donald R. Swortwood
| Sociétés | Poste | Début |
|---|---|---|
Vaxiion Therapeutics, Inc.
 Vaxiion Therapeutics, Inc. BiotechnologyHealth Technology Vaxiion Therapeutics, Inc. operates as a biotechnology company. Its nanodelivery platforms are based on genetically engineered, non-living bacterial minicells that are capable of packaging, targeting and delivering a wide array of therapeutically relevant molecules (including protein toxins, small molecule drugs, RNAi, plasmids, peptides and imaging agents) directly to cancer cells. The company was founded by Roger Allen Sabbadini, Neil L. Berkley and William Gerhart in 2000 and is headquartered in San Diego, CA. | Directeur/Membre du Conseil | 16/02/2010 |
Anciens postes connus de Donald R. Swortwood
| Sociétés | Poste | Fin |
|---|---|---|
Western States Investment Corp.
 Western States Investment Corp. Investment ManagersFinance Western States Investment Corp ( Western States Investment ) is a private equity firm founded in 1976. The firm is headquartered in San Diego, California. | President | - |
Lpath, Inc.
 Lpath, Inc. BiotechnologyHealth Technology Lpath, Inc. operates as a biotechnology company, which focuses on the discovery and development of lipidomic-based therapeutic antibodies, an emerging field of medical science that targets bioactive signaling lipids to treat a wide range of human diseases. It develops three drug candidates, each of them into clinical trials, and built evidence to support their approach of targeting bioactive lipids to treat a wide range of diseases. The company was founded by Roger Allen Sabbadini in September 1997 and is headquartered in San Diego, CA. | Directeur/Membre du Conseil | - |
Formation de Donald R. Swortwood
| Stanford University | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Lpath, Inc.
Lpath, Inc. BiotechnologyHealth Technology Lpath, Inc. operates as a biotechnology company, which focuses on the discovery and development of lipidomic-based therapeutic antibodies, an emerging field of medical science that targets bioactive signaling lipids to treat a wide range of human diseases. It develops three drug candidates, each of them into clinical trials, and built evidence to support their approach of targeting bioactive lipids to treat a wide range of diseases. The company was founded by Roger Allen Sabbadini in September 1997 and is headquartered in San Diego, CA. | Health Technology |
Western States Investment Corp.
Western States Investment Corp. Investment ManagersFinance Western States Investment Corp ( Western States Investment ) is a private equity firm founded in 1976. The firm is headquartered in San Diego, California. | Finance |
Vaxiion Therapeutics, Inc.
Vaxiion Therapeutics, Inc. BiotechnologyHealth Technology Vaxiion Therapeutics, Inc. operates as a biotechnology company. Its nanodelivery platforms are based on genetically engineered, non-living bacterial minicells that are capable of packaging, targeting and delivering a wide array of therapeutically relevant molecules (including protein toxins, small molecule drugs, RNAi, plasmids, peptides and imaging agents) directly to cancer cells. The company was founded by Roger Allen Sabbadini, Neil L. Berkley and William Gerhart in 2000 and is headquartered in San Diego, CA. | Health Technology |
